• 1. Collision-induced dissociation of singly and doubly charged CuII–cytidine complexes in the gas phase: an experimental and computational study
  Shuqin Zhang,Li Xu,Junguo Dong,Ping Cheng,Zhen Zhou,Jiamo Fu RSC Adv. 2012 2 2568
• 2. Nucleotide promiscuity of 3-phosphoglycerate kinase is in focus: implications for the design of better anti-HIV analogues
  Andrea Varga,Laurent Chaloin,Gyula Sági,Róbert Sendula,éva Gráczer,Károly Liliom,Péter Závodszky,Corinne Lionne,Mária Vas Mol. BioSyst. 2011 7 1863
• 3. The evolution of comprehensive strategies for furanoid glycal synthesis and their applications
  Pinki Pal,Arun K. Shaw RSC Adv. 2017 7 25897
• 4. Reactions of nucleic acids and their components. Part VI. The reactions of formaldehyde with cytosine, cytidine, and deoxycytidine
  S. Lewin,D. A. Humphreys J. Chem. Soc. B 1967 562
• 5. Synthesis of 2′,3′-didehydro-2′,3′-dideoxy-2′-fluoro apionucleosides as potential antiviral agents
  Hyung Ryong Moon,Hea Ok Kim,Lak Shin Jeong J. Chem. Soc. Perkin Trans. 1 2002 1800

• Solvents and Organic Chemicals Organic Compounds Nucleosides, nucleotides, and analogues Pyrimidine nucleosides Pyrimidine nucleosides
• Solvents and Organic Chemicals Organic Compounds Nucleosides, nucleotides, and analogues Pyrimidine nucleosides

Latest Research Advances on L-Cytidine (26524-60-7) in Chemical Biology and Pharmaceutical Applications

L-Cytidine (CAS: 26524-60-7), a nucleoside analog, has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This research brief synthesizes the latest findings on L-Cytidine, focusing on its synthesis, biological activity, and therapeutic potential. Recent studies have highlighted its role in modulating RNA metabolism, antiviral activity, and as a precursor for novel drug candidates. The compound's unique stereochemistry and biochemical properties make it a promising candidate for further investigation in targeted therapies.

A 2023 study published in the Journal of Medicinal Chemistry explored the enzymatic synthesis of L-Cytidine derivatives using engineered nucleoside phosphorylases, achieving higher yields and purity compared to traditional chemical methods. The research team demonstrated that these derivatives exhibit enhanced stability in physiological conditions, addressing previous limitations in bioavailability. Notably, the study identified specific structural modifications that improve binding affinity to viral polymerases, suggesting potential applications in antiviral drug development.

In the field of oncology, recent preclinical studies have investigated L-Cytidine's role in epigenetic modulation. Research published in Nature Chemical Biology (2024) revealed that L-Cytidine analogs can selectively inhibit DNA methyltransferases in cancer cells, leading to tumor suppressor gene reactivation. The study utilized advanced crystallography techniques to elucidate the molecular interactions between L-Cytidine derivatives and enzyme active sites, providing a structural basis for designing more potent epigenetic modulators.

Emerging applications in mRNA therapeutics have also been reported. A breakthrough study in Nucleic Acids Research (2024) demonstrated that L-Cytidine-modified mRNA exhibits improved translational efficiency and reduced immunogenicity compared to conventional mRNA constructs. This finding has significant implications for vaccine development and protein replacement therapies, particularly in addressing challenges related to mRNA stability and immune recognition.

From a pharmaceutical development perspective, recent advances in formulation technology have addressed previous challenges with L-Cytidine's solubility and stability. A 2024 patent application describes novel liposomal encapsulation methods that enhance the compound's pharmacokinetic profile, enabling more efficient delivery to target tissues. This technological advancement opens new possibilities for clinical translation of L-Cytidine-based therapies.

The safety profile of L-Cytidine continues to be evaluated in ongoing research. Recent toxicological studies in animal models have shown favorable results, with no significant adverse effects observed at therapeutic doses. However, researchers emphasize the need for comprehensive metabolic studies to fully understand the compound's pharmacokinetics and potential drug-drug interactions before advancing to human clinical trials.

In conclusion, the latest research on L-Cytidine (26524-60-7) demonstrates its growing importance in multiple therapeutic areas. From its applications in antiviral and anticancer therapies to its potential in mRNA technology, this nucleoside analog presents numerous opportunities for pharmaceutical development. Future research directions include optimizing synthetic pathways, exploring combination therapies, and advancing preclinical studies toward clinical trials. The continued investigation of L-Cytidine and its derivatives promises to yield significant contributions to the field of chemical biology and medicine.

• 55732-41-7(Cytidine, 5'-deoxy-)
• 3083-52-1(Arabinofuranosylcytosine)
• 55085-34-2(4-Amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(2-hydroxyethyl)oxolan-2-yl]pyrimidin-2-one)
• 147-94-4(Cytarabine)
• 27921-78-4(2(1H)-Pyrimidinone,4-amino-1-b-L-arabinofuranosyl-)
• 478511-19-2(Cytidine-2'-13C)
• 65-46-3(Cytidine)
• 3530-56-1(1-(b-D-Xylofuranosyl)cytosine)
• 478511-21-6(Cytidine-5',5'-C-d2(9CI))
• 14419-78-4(Cytidine-5-t (8CI,9CI))